Clinically Applicable Models to Characterize BRCA1 and BRCA2 Variants of Uncertain Significance

被引:69
|
作者
Spearman, Andrew D.
Sweet, Kevin
Zhou, Xiao-Ping
McLennan, Jane
Couch, Fergus J.
Toland, Amanda Ewart [1 ]
机构
[1] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1200/JCO.2008.17.8228
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Twenty percent of individuals with a strong family and/or personal history of breast and ovarian cancer carry a deleterious mutation in BRCA1 or BRCA2. Identification of mutations in these genes is extremely beneficial for patients pursuing risk reduction strategies. Approximately 7% of individuals who have genetic testing of BRCA1 and BRCA2 carry a variant of uncertain significance (VUS), making clinical management less certain. The majority of identified VUS occur only in one to two individuals; these variants are not able to be classified using current classification models with segregation analysis components. Methods To develop a clinically applicable method that can predict the pathogenicity of VUS that does not require familial information or segregation analysis, we identified characteristics of breast or ovarian tumors that distinguished sporadic tumors from tumors with BRCA1 or BRCA2 mutations. Study participants included individuals with known deleterious mutations in BRCA1 or BRCA2 and individuals with classified or unclassified BRCA variants. Results We applied the models to 57 tumors with 43 different deleterious BRCA mutations and 57 tumors with 54 unique classified and unclassified BRCA variants. Of the 33 previously unclassified VUS studied, we found evidence of neutrality for 21. Conclusion Our models showed 98% sensitivity and 76% specificity for predicting classified DNA changes. We classified 64% of unknown variants as neutral. Classification of VUS as neutral will have immediate benefit for those individuals and their family members. These models are adaptable for the clinic and will be useful for individuals with limited available family history.
引用
收藏
页码:5393 / 5400
页数:8
相关论文
共 50 条
  • [31] In Brief: BRCA1 and BRCA2
    Foulkes, William D.
    Shuen, Andrew Y.
    JOURNAL OF PATHOLOGY, 2013, 230 (04): : 347 - 349
  • [32] Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes
    Akbari, Mohammad R.
    Zhang, Shiyu
    Fan, Isabel
    Royer, Robert
    Li, Song
    Risch, Harvey
    McLaughlin, John
    Rosen, Barry
    Sun, Ping
    Narod, Steven A.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (11) : 783 - 786
  • [33] Family planning in carriers of BRCA1 and BRCA2 pathogenic variants
    Haddad, Jessica M.
    Robison, Katina
    Beffa, Lindsey
    Laprise, Jessica
    ScaliaWilbur, Jennifer
    Raker, Christina A.
    Clark, Melissa A.
    Hofstatter, Erin
    Dalela, Disha
    Brown, Amy
    Bradford, Leslie
    Toland, Maris
    Stuckey, Ashley
    JOURNAL OF GENETIC COUNSELING, 2021, 30 (06) : 1570 - 1581
  • [34] Validity of models for predicting BRCA1 and BRCA2 mutations
    Parmigiani, Giovanni
    Chen, Sining
    Iversen, Edwin S., Jr.
    Friebel, Tara M.
    Finkelstein, Dianne M.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Weber, Barbara L.
    Eisen, Andrea
    Malone, Kathleen E.
    Daling, Janet R.
    Hsu, Li
    Ostrander, Elaine A.
    Peterson, Leif E.
    Schildkraut, Joellen M.
    Isaacs, Claudine
    Corio, Camille
    Leondaridis, Leoni
    Tomlinson, Gail
    Amos, Christopher I.
    Strong, Louise C.
    Berry, Donald A.
    Weitzel, Jeffrey N.
    Sand, Sharon
    Dutson, Debra
    Kerber, Rich
    Peshkin, Beth N.
    Euhus, David M.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (07) : 441 - 450
  • [35] Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
    Li, Shuai
    Silvestri, Valentina
    Leslie, Goska
    Rebbeck, Timothy R.
    Neuhausen, Susan L.
    Hopper, John L.
    Nielsen, Henriette Roed
    Lee, Andrew
    Yang, Xin
    McGuffog, Lesley
    Parsons, Michael T.
    Andrulis, Irene L.
    Arnold, Norbert
    Belotti, Muriel
    Borg, Ake
    Buecher, Bruno
    Buys, Saundra S.
    Caputo, Sandrine M.
    Chung, Wendy K.
    Colas, Chrystelle
    Colonna, Sarah, V
    Cook, Jackie
    Daly, Mary B.
    de la Hoya, Miguel
    de Pauw, Antoine
    Delhomelle, Helene
    Eason, Jacqueline
    Engel, Christoph
    Evans, D. Gareth
    Faust, Ulrike
    Fehm, Tanja N.
    Fostira, Florentia
    Fountzilas, George
    Frone, Megan
    Garcia-Barberan, Vanesa
    Garre, Pilar
    Gauthier-Villars, Marion
    Gehrig, Andrea
    Glendon, Gord
    Goldgar, David E.
    Golmard, Lisa
    Greene, Mark H.
    Hahnen, Eric
    Hamann, Ute
    Hanson, Helen
    Hassan, Tiara
    Hentschel, Julia
    Horvath, Judit
    Izatt, Louise
    Janavicius, Ramunas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1529 - +
  • [36] Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
    Kwon, Won Kyung
    Jang, Hyeok-Jae
    Lee, Jeong Eon
    Park, Yeon Hee
    Ryu, Jai Min
    Yu, Jonghan
    Jang, Ja-Hyun
    Kim, Jong-Won
    CANCER GENETICS, 2022, 266 : 19 - 27
  • [37] Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"
    Dines, Jennifer N.
    Shirts, Brian H.
    Slavin, Thomas P.
    Walsh, Tom
    King, Mary-Claire
    Fowler, Douglas M.
    Pritchard, Colin C.
    GENETICS IN MEDICINE, 2020, 22 (05) : 825 - 830
  • [38] Functional Evaluation of unclassified variants in the genes BRCA1 and BRCA2
    Graeser, M.
    Becker, A.
    Wappenschmidt, B.
    Landwehr, C.
    Hilger, T.
    Baus, W.
    Weber, R.
    Mallmann, P.
    Schmutzler, R. K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 742 - 742
  • [39] Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes
    Jessemae L. Welsh
    Tanya L. Hoskin
    Courtney N. Day
    Abigail S. Thomas
    Jodie A. Cogswell
    Fergus J. Couch
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 3067 - 3072
  • [40] Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes
    Welsh, Jessemae L.
    Hoskin, Tanya L.
    Day, Courtney N.
    Thomas, Abigail S.
    Cogswell, Jodie A.
    Couch, Fergus J.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (10) : 3067 - 3072